Lane CA, Hardy J, Schott JM. Alzheimer’s disease. Eur J Neurol. 2018;25(1):59–70.

Article  CAS  PubMed  Google Scholar 

Yiannopoulou KG, Papageorgiou SG. Current and future treatments in Alzheimer disease: an update. J Cent Nerv Syst Dis. 2020;12:1179573520907397.

Article  PubMed  PubMed Central  Google Scholar 

Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413–46.

Article  PubMed  PubMed Central  Google Scholar 

Kloske CM, Wilcock DM. The important interface between apolipoprotein E and neuroinflammation in Alzheimer’s disease. Front Immunol. 2020;11:754.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou C, Ni W, Zhu T, Dong S, Sun P, Hua F. Cellular reprogramming and its potential application in Alzheimer’s disease. Front Neurosci. 2022;7(16):884667.

Article  Google Scholar 

Vance RE, Isberg RR, Portnoy DA. Patterns of pathogenesis: discrimination of pathogenic and nonpathogenic microbes by the innate immune system. Cell Host Microbe. 2009;6(1):10–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fakhoury M. Microglia and astrocytes in Alzheimer’s disease: implications for therapy. Curr Neuropharmacol. 2018;16(5):508–18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou C, Sun X, Hu Y, Song J, Dong S, Kong D, et al. Genomic deletion of TLR2 induces aggravated white matter damage and deteriorated neurobehavioral functions in mouse models of Alzheimer’s disease. Aging (Albany NY). 2019;11(17):7257–73.

Article  CAS  PubMed  Google Scholar 

Yadav S, Verma V, Singh Dhanda R, Yadav M. Insights into the toll-like receptors in sexually transmitted infections. Scand J Immunol. 2021;93(1):e12954.

Article  CAS  PubMed  Google Scholar 

Shi H, Hua X, Kong D, Stein D, Hua F. Role of Toll-like receptor mediated signaling in traumatic brain injury. Neuropharmacology. 2019;145(Pt B):259–67.

Article  CAS  PubMed  Google Scholar 

Gambuzza ME, Sofo V, Salmeri FM, Soraci L, Marino S, Bramanti P. Toll-like receptors in Alzheimer’s disease: a therapeutic perspective. CNS Neurol Disord Drug Targets. 2014;13(9):1542–58.

Article  CAS  PubMed  Google Scholar 

Mokhtari Y, Pourbagheri-Sigaroodi A, Zafari P, Bagheri N, Ghaffari SH, Bashash D. Toll-like receptors (TLRs): an old family of immune receptors with a new face in cancer pathogenesis. J Cell Mol Med. 2021;25(2):639–51.

Article  CAS  PubMed  Google Scholar 

Li L, Acioglu C, Heary RF, Elkabes S. Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases. Brain Behav Immun. 2021;91:740–55.

Article  CAS  PubMed  Google Scholar 

Lin J, Chang Q, Dai X, Liu D, Jiang Y, Dai Y. Early secreted antigenic target of 6-kDa of Mycobacterium tuberculosis promotes caspase-9/caspase-3-mediated apoptosis in macrophages. Mol Cell Biochem. 2019;457(1–2):179–89.

Article  CAS  PubMed  Google Scholar 

Bianchi F, Pretto S, Tagliabue E, Balsari A, Sfondrini L. Exploiting poly(I:C) to induce cancer cell apoptosis. Cancer Biol Ther. 2017;18(10):747–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu L, Botos I, Wang Y, Leonard JN, Shiloach J, Segal DM, et al. Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science. 2008;320(5874):379–81.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Di S, Zhou M, Pan Z, Sun R, Chen M, Jiang H, et al. Combined adjuvant of poly I: C improves antitumor effects of CAR-T cells. Front Oncol. 2019;9:241.

Article  PubMed  PubMed Central  Google Scholar 

Chuang HC, Lin HY, Liao PL, Huang CC, Lin LL, Hsu WM, et al. Immunomodulator polyinosinic-polycytidylic acid enhances the inhibitory effect of 13-cis-retinoic acid on neuroblastoma through a TLR3-related immunogenic-apoptotic response. Lab Invest. 2020;100(4):606–18.

Article  CAS  PubMed  Google Scholar 

Chen CY, Liu HY, Hsueh YP. TLR3 downregulates expression of schizophrenia gene Disc1 via MYD88 to control neuronal morphology. EMBO Rep. 2017;18(1):169–83.

Article  CAS  PubMed  Google Scholar 

Zhang SY. Herpes simplex virus encephalitis of childhood: inborn errors of central nervous system cell-intrinsic immunity. Hum Genet. 2020;139(6–7):911–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lathia JD, Okun E, Tang SC, Griffioen K, Cheng A, Mughal MR, et al. Toll-like receptor 3 is a negative regulator of embryonic neural progenitor cell proliferation. J Neurosci. 2008;28(51):13978–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chavez-Valdez R, Mottahedin A, Stridh L, Yellowhair TR, Jantzie LL, Northington FJ, et al. Evidence for sexual dimorphism in the response to TLR3 activation in the developing neonatal mouse brain: a pilot study. Front Physiol. 2019;10:306.

Article  PubMed  PubMed Central  Google Scholar 

Schau I, Michen S, Hagstotz A, Janke A, Schackert G, Appelhans D, et al. Targeted delivery of TLR3 agonist to tumor cells with single chain antibody fragment-conjugated nanoparticles induces type I-interferon response and apoptosis. Sci Rep. 2019;9(1):3299.

Article  PubMed  PubMed Central  Google Scholar 

Paouri E, Georgopoulos S. Systemic and CNS inflammation crosstalk: implications for Alzheimer’s disease. Curr Alzheimer Res. 2019;16(6):559–74.

Article  CAS  PubMed  Google Scholar 

Yang Y, Zhang Z. Microglia and Wnt pathways: prospects for inflammation in Alzheimer’s disease. Front Aging Neurosci. 2020;12:110.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang J, Malone F, Go M, Kou J, Lim JE, Caughey RC, et al. Lipopolysaccharide-induced exosomal miR-146a is involved in altered expression of Alzheimer’s risk genes via suppression of TLR4 signaling. J Mol Neurosci. 2021;71(6):1245–55.

Article  CAS  PubMed  Google Scholar 

Walker DG, Tang TM, Lue LF. Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer’s disease brains. Exp Neurol. 2018;309:91–106.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kinney JW, Bemiller SM, Murtishaw AS, Leisgang AM, Salazar AM, Lamb BT. Inflammation as a central mechanism in Alzheimer’s disease. Alzheimers Dement (N Y). 2018;4:575–90.

Article  PubMed  Google Scholar 

Hu Y, Sun X, Wang S, Zhou C, Lin L, Ding X, et al. Toll-like receptor-2 gene knockout results in neurobehavioral dysfunctions and multiple brain structural and functional abnormalities in mice. Brain Behav Immun. 2021;91:257–66.

Article  CAS  PubMed  Google Scholar 

Hua F, Wang J, Ishrat T, Wei W, Atif F, Sayeed I, et al. Genomic profile of Toll-like receptor pathways in traumatically brain-injured mice: effect of exogenous progesterone. J Neuroinflammation. 2011;8:42.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Franco R, Lillo A, Rivas-Santisteban R, Reyes-Resina I, Navarro G. Microglial adenosine receptors: from preconditioning to modulating the M1/M2 balance in activated cells. Cells. 2021;10(5):1124.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Benameur T, Soleti R, Porro C. The potential neuroprotective role of free and encapsulated quercetin mediated by miRNA against neurological diseases. Nutrients. 2021;13(4):1318.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Azam S, Haque ME, Kim IS, Choi DK. Microglial turnover in ageing-related neurodegeneration: therapeutic avenue to intervene in disease progression. Cells. 2021;10(1):150.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McQuade A, Blurton-Jones M. Microglia in Alzheimer’s disease: exploring how genetics and phenotype influence risk. J Mol Biol. 2019;431(9):1805–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mesquita SD, Ferreira AC, Sousa JC, Correia-Neves M, Sousa N, Marques F. Insights on the pathophysiology of Alzheimer’s disease: the crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system. Neurosci Biobehav Rev. 2016;68:547–62.